DELAFIELD, Wis. (Stockpickr) -- The market experienced heavy selling pressure on Thursday, with the Dow Jones Industrial Average dropping 160 points and the S&P 500 sliding lower by 17 points.
>>5 Stocks Under $10 Set to Soar
Despite that bearish action, one chart pattern continues to show promise: beaten-down stocks that have entered extremely oversold territory. Stocks that share these characteristics have been working in this tough environment. Take, for example, biopharmaceutical stock Celldex Therapeutics (CLDX), which dropped from its February high of $33.33 a share to its May low of $10.76 a share. This stock has exploded higher over the last few trading sessions, with shares ripping from $10.76 to Wednesday's intraday high of $15.97 a share.
Another great example is intellectual property player Spherix (SPEX), which the bears pressured lower from its January high of $10.40 a share to its recent low of $1.19 a share. Shares of SPEX finally saw a respite to the selling pressure this week, when the stock rebounded off that $1.19 low and exploded higher to its intraday high on Wednesday of $1.94 a share.
Top 5 Tech Companies To Watch In Right Now: Zep Inc.(ZEP)
Zep Inc. produces and markets cleaning and maintenance chemicals, and related products and services for commercial, industrial, institutional and consumer applications. Its products include anti-bacterial and industrial hand care products, cleaners, degreasers, deodorizers, disinfectants, floor finishes, sanitizers, pest- and weed-control products, air-care products and delivery systems, and various automotive maintenance chemicals. The company markets its products and services under various brands, such as Zep, Selig, ArmorAll, Niagara, Enforcer, Zep Commercial, RedMax Pro, Rubbermaid Commercial, Original Bike Spirits, Country Vet, Zep Professional, Microbemax, Misty, TimeMist, i-Chem, TimeWick, and Next Dimension brands, as well as private label and original equipment manufacturer private brands. It serves customers in industrial maintenance, janitorial/sanitation, and automotive markets; transportation, food processing, industrial manufacturing, and food service industr ies; and contractors, small business owners, and homeowners in the United States, Canada, and Europe. The company was founded in 1937 and is headquartered in Atlanta, Georgia.
Advisors' Opinion:- [By Seth Jayson]
When judging a company's prospects, how quickly it turns cash outflows into cash inflows can be just as important as how much profit it's booking in the accounting fantasy world we call "earnings." This is one of the first metrics I check when I'm hunting for the market's best stocks. Today, we'll see how it applies to Zep (NYSE: ZEP ) .
- [By Seth Jayson]
Basic guidelines
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Zep (NYSE: ZEP ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Zep doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue increased 3.5%, and inventory increased 11.8%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue grew 7.7%, and inventory grew 11.8%. Over the sequential quarterly period, the trend looks OK but not great. Revenue grew 3.4%, and inventory grew 4.7%. - [By Laura Brodbeck]
Monday
Earnings Releases Expected: Sonic Corp (NASDAQ: SONC), Calavo Growers, Inc. (NASDAQ: CVGW), Zep Inc. (NYSE: ZEP) Economic Releases Expected: �Spanish services PMI, Italian services PMI, French services PMI, German services PMI, eurozone services PMI, British services PMI, eurozone investor confidence, German CPI, Australian trade balanceTuesday
Top 10 Dow Dividend Stocks For 2014: Albany Molecular Research Inc.(AMRI)
Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States, Europe, and Asia. The company offers a range of drug discovery services, including assay development and design, screening, screening library, natural product, medicinal chemistry, computer-aided drug discovery, in vitro ADMET, and bioanalytical services. It also provides chemical development services consisting of process research and development, custom synthesis, process safety assessment, scale-up capabilities, high potency and controlled substances, analytical services, preformulation services and physical characterization, preparative chromatography, IND support services, fermentation development and optimization, and building blocks collection and database services. In addition, the company offers chemical synthesis and manufacturing services. It manufactures active pharmaceutical ingredients (APIs)and advanced intermediate s. Further, the company provides contract manufacturing services in sterile syringe and vial filling for small molecule drug products and biologicals. Additionally, it offers formulation services, including neat API or pharmaceutical blend in capsules; PIB for solution and suspension; blending and sieving; milling; tableting; rheology; roller compaction; wet granulation; and fluid bed processing, including wurster coating; and associated analytical testing services for dosage formulation products, as well as provides analytical services, such as impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; analytical and preparative supercritical fluid chromatography; preparative chromatography; good laboratory practices bioanalytical services; and regulatory support/quality assurance services. The company was founded in 1991 and is based in Albany, New York.
Advisors' Opinion:- [By GuruFocus]
George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV).
Top 10 Dow Dividend Stocks For 2014: Capex SA (CAPX)
Capex SA is an Argentina-based company primarily engaged in the energy sector. The Company�� main activities include the generation and sale of electric energy; the exploration and exploitation of oil and gas, and the production, distribution and marketing of propane, butane and gasoline. The Company operates a liquefied petroleum gas (LPG) plant which is located in the province of Neuquen. As of December 31, 2011, the Company owned such subsidiaries as Hychico SA and Servicios Buproneu SA. Advisors' Opinion:- [By Dividends4Life]
Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1. Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number CVX is trading at a discount to only 3.) above. The stock is trading at a 44.9% premium to its calculated fair value of $82.00. CVX did not earn any Stars in this section. Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description: 1. Free Cash Flow Payout 2. Debt To Total Capital 3. Key Metrics 4. Dividend Growth Rate 5. Years of Div. Growth 6. Rolling 4-yr Div. > 15% CVX earned two Stars in this section for 2.) and 3.) above. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. CVX earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1912 and has increased its dividend payments for 27 consecutive years. Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1. NPV MMA Diff. 2. Years to > MMA The NPV MMA Diff. of the $256 is below the $800 target I look for in a stock that has increased dividends as long as CVX has. The stock's current yield of 3.37% exceeds the 3.31% estimated 20-year average MMA rate. Memberships and Peers: CVX is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: BP plc (BP) with a 4.7% yield, Exxon Mobil
Top 10 Dow Dividend Stocks For 2014: Capella Education Company(CPLA)
Capella Education Company operates as an online postsecondary education services company in the United States and internationally. The company, trough its Capella University, offers various doctoral, master?s, and bachelor?s programs primarily for working adults in public service leadership, behavioral health and human services, business management and technology, and education markets; and online distance learning services for degree-entry programs and doctoral level programs in various disciplines, including business, management, psychology, law, and computing disciplines. It also provides learner support services, such as academic services comprising new learner orientation, technical support, academic advising, research services, online tutoring, and writing services; and administrative services through the telephone and Internet. In addition, the company?s learner support services include library services, such as access to collection of online journals, eBooks, an d interlibrary loan services; and career center services comprising career counseling, job search advising, and career management support services to learners and alumni. As of December 31, 2011, the company offered approximately 1,450 online courses and 43 academic programs with 140 specializations to approximately 37,000 learners. Capella Education Company was founded in 1991 and is headquartered in Minneapolis, Minnesota.
Advisors' Opinion:- [By Jeremy Bowman]
So what: ITT Educational Services (NYSE: ESI ) reported earnings earlier this morning, shooting up 30%, and earlier this week,�Capella Education (NASDAQ: CPLA ) jumped 15% after reporting, and is now approaching a new 52-week high. The education sector has gotten hammered over the last couple of years, but investors seem to be getting the feeling that enrollment numbers are bottoming. One exception was DeVry (NYSE: DV ) , which fell sharply after reporting earnings earlier this week, but still managed to gain 5.8% today.
Top 10 Dow Dividend Stocks For 2014: Carpenter Technology Corp (CRS)
Carpenter Technology Corporation (Carpenter), incorporated in 1904, is engaged in the manufacturing, fabrication and distribution of specialty metals. The Company has three reportable segments: Advanced Metals Operations, Premium Alloys Operations, and Emerging Ventures., The Company develops, manufactures and distributes cast/wrought and powder metal stainless steels and special alloys, including high-temperature alloys, controlled expansion alloys, ultra high-strength alloys, implantable alloys, tool and die steels and other specialty metals, as well as cast/wrought titanium alloys. Carpenter provides material solutions to the aerospace, industrial, energy, medical, consumer products and automotive industries. In June 2011, Carpenter acquired Oilfield Alloys Pte. Ltd. In February 2012, the Company acquired Latrobe Specialty Metals, Inc.
Carpenter�� Advanced Metals Operations (AMO) segment includes the manufacturing and distribution of high-temperature and high-strength metal alloys, stainless steels, and titanium in the form of small bars and rods, wire, narrow strip and powder. Products in this segment go through more finishing operations, such as rolling, turning, grinding, drawing, and atomization, than products in its PAO segment. Also, sales in the AMO segment are spread across many end-use markets, including the aerospace, industrial, consumer, automotive, and medical industries. AMO products are sold under the Carpenter, Dynamet, Talley, Carpenter Powder Products and Aceros Fortuna brand names.
Its Premium Alloys Operations (PAO) segment includes the manufacturing and distribution of high temperature and high strength metal alloys and stainless steels in the form of ingots, billets, large bars and hollows. Also, the PAO segment includes conversion processing of metal for other specialty metals companies. A significant portion of PAO sales are to customers in the aerospace and energy industries. The Emerging Ventures segment includes the operations of the recently ! completed acquisitions of Amega West and Oilfield Alloys. The sales of Amega West are to customers in the energy end use market.
The Company��s major classes of products include special alloys, stainless steels and titanium products. special alloys are used in critical components such as rings, discs and fasteners and include heat resistant alloys that range from slight modifications of stainless steels to complex nickel and cobalt base alloys as well as alloys for electronic, magnetic and electrical applications with controlled thermal expansion characteristics, or high electrical resistivity or special magnetic characteristics. Its stainless products include a range of corrositon resistant alloys including conventional stainless steels and many proprietary grades for special applications. Titanium products include corrosion resistant, specialized metal with a combination of high strength and low density.
Advisors' Opinion:- [By Lee Jackson]
Industrials: Carpenter Technology Corp. (NYSE: CRS) manufactures, fabricates�and distributes specialty metals worldwide. It operates in three segments: Specialty Alloys Operations, Latrobe and Performance Engineered Products. Credit Suisse expects earnings per share growth to average 32% in fiscal years 2014 to 2016. This should be driven by double-digit growth in commercial aerospace and energy, coupled with higher incremental margins as a result of improving mix, asset utilization�and Latrobe synergies. The price target for the stock is $72, though the consensus target is lower at $65. Investors are paid a 1.2% dividend. A move to the target price would represent a gain of 20%
- [By Jon C. Ogg]
Carpenter Technology Corp. (NYSE: CRS) is one that remains well positioned within Aerospace materials sector, despite industry inventory adjustments still lingering. The firm believes that the value of the Athens facility is underappreciated and is likely to open sooner than the official April date. Sterne Agee also believes that 2014 will be the beginning of a multi-year growth cycle with a significant opportunity to improve cash generation. It even sees 20%+ upside to current levels as 2014 will be a transformational year.
- [By Jake L'Ecuyer]
Carpenter Technology (NYSE: CRS) was down, falling 2.71 percent to $64.64 after the company reported preliminary Q3 GAAP earnings of $0.54 to $0.58 per share, versus analysts' estimates of $0.72 per share.
Top 10 Dow Dividend Stocks For 2014: GreenHaven Continuous Commodity Index Master Fund (GCC)
GreenHaven Continuous Commodity Index Fund (the Fund), incorporated on October 27, 2006, is a statutory trust. The investment objective of the Fund and The GreenHaven Continuous Commodity Index Master Fund (the Master Fund) is to reflect the performance of the Index, over time, less the expenses of the operations of the Fund and the Master Fund. The Master Fund is a wholly owned subsidiary of the Fund and the Managing Owner. CSC Trust Company (the Trustee) is the sole trustee of the Fund and the Master Fund.
The Master Fund issues common units of beneficial interest, or Master Fund Units, which represent units of fractional undivided beneficial interest in and ownership of the Master Fund. The Fund invests substantially all of its assets in the Master Fund in a master-feeder structure. The Fund holds no investment assets other than Master Fund Units.
Advisors' Opinion:- [By Richard Stavros]
Whereas in the 1970s there were limited ways to hedge against inflation, now there is a cornucopia of currency and international commodities instruments that can not only hedge against inflation but other global shocks, such as market bubbles and even war.
And it is these very scenarios that investors have been worried about. Since the beginning of the year, stocks, bonds and just about any investment you can think of have gyrated wildly at various times amid concerns of war, inflation and the possibility that the U.S. equity market is overvalued and headed for a correction.
In response, some market analysts in Bloomberg news reports have offered any number of wildly unsubstantiated statements for why investors should ignore today’s perils. They dismiss the danger posed by Russia�� annexation of Ukraine�� Crimea region (��utin will stop short of other countries or war with the West��. They also argue that the Federal Reserve chairwoman misspoke (��anet Yellen really didn�� mean a rate hike is coming soon. Inflation is under control. It was a rookie mistake��.
For my money, here’s the most outrageous: The Shiller Cyclically adjusted P/E metric which has predicted the 1929, 2000 and 2007 downturns doesn�� apply (��uggests only a slightly expensive market with low to moderate returns going forward on average��.
With new records being set by the S&P 500 in the last few months, it stands to reason that some investors have not needed much convincing to stay all in and buying. This mindset has prevailed, even as the impact of a Russian war or conflict, runaway inflation or a market correction could be devastating to investor portfolios, taking years to recover.
If you��e never thought of certain investments as “insurance,” it�� time to start now. Protecting wealth is as important as building wealth. And as previously mentioned, we have found that the Inflation Survival Letter�� Thri - [By Richard Stavros]
GreenHaven Continuous Commodity Index (GCC) is an exchange-traded fund that aims to track the Equal Weight Continuous Commodity Total Return Index (CCI-TR), which provides exposure to diversified commodities. The index is up 4.75% year-to-date, and up 24.63% over the last five years.
Top 10 Dow Dividend Stocks For 2014: Revive Therapeutics Ltd (RVV)
Revive Therapeutics Ltd., formerly Mercury Capital II Limited, is focused on acquiring, developing and commercializing treatments for major market opportunities such as sleep apnea, gout and rare diseases. The Company is focused on underserved medical needs such as opioid-induced respiratory depression in high risk patients with sleep apnea, gout, and Rett Syndrome. The Company is also developing a next generation analog of REV-001, which is an improvement of the original compound and it will have the potential to treat new diseases that would otherwise remain untreated with the original compound, such as rare diseases, breathing disorders, and cognitive dysfunction. Advisors' Opinion:- [By Holly LaFon]
Whitney George is Director of Investments, Managing Director, and a Portfolio Manager of Royce & Associates, LLC, investment advisor to The Royce Funds. He serves as portfolio manager for Royce Premier Fund (RPR), Royce Low-Priced Stock Fund (RLP), Royce Global Value Fund (RGV), Royce SMid-Cap Value Fund (RSV), and Royce Focus Trust (FUND). He also serves as assistant portfolio manager for Royce Micro-Cap Fund (RMC), Royce Value Fund (RVV), Royce Value Plus Fund (RVP), Royce Focus Value Fund (RFV), and Royce Capital Fund ��Micro-Cap Portfolio (RCM). Mr. George's thoughts in this interview concerning the stock market are solely his own and, of course, there can be no assurance with regard to future market movements.
No comments:
Post a Comment